共 50 条
- [42] Guselkumab: an anti-IL-23 antibody for the treatment of moderate-to-severe plaque psoriasis European Journal of Dermatology, 2021, 31 : 3 - 16
- [47] Population Pharmacokinetic Modeling of Ustekinumab, a Human Monoclonal Antibody Targeting IL-12/23p40, in Patients With Moderate to Severe Plaque Psoriasis JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (02): : 162 - 175